Pediatric Hematology and Oncology Center Integrated by Telemedicine: Experience, Challenges and First Results of a Cross Border Network
Abstract
:1. Introduction
2. Materials and Methods
2.1. Preparation of the Temicare Project
- The Leader—Department of Pediatric Hematology and Oncology, University of Medicine in Greifswald, Germany (Greifswald), with great experience in treatment of pediatric oncology patients, with a special focus in neuroblastoma immunotherapy, and partners.
- Department of Pediatrics, Hemato-Oncology and Gastroenterology, Pomeranian Medical University, Szczecin, Poland (Szczecin I), as the biggest pediatric oncology and hematology department in the region of Western Pomerania on the Polish side of the border, treating children with cancer from the whole region on the Polish site. *
- Department of Pediatrics, Oncology and Immunology, Pomeranian Medical University, Szczecin, Poland (Szczecin II). *
- Department of Pediatric Oncology and Hematology, Jagiellonian University Medical College in Kraków, Poland (Kraków), invited to the project as an external partner as the Polish national coordinating center for neuroblastoma therapy, with long-time established cooperation with the Greifswald University of Medicine.
- To involve families in the decision-making process of diagnosis and therapy;
- To create, develop and introduce the online hybrid system of additional education in the field of pediatric oncology and hematology for all centers participating in the project with the use of the internet network connecting all centers;
- To assess the feasibility and efficacy of this form of education with the use of the tools created for this specific purpose.
- Parents and care givers of patients;
- Staff physicians;
- Residents in pediatrics as well as in pediatric hematology and oncology;
- Students in training (regular and practical) in pediatrics;
- Members of the OncoGroup (the abovementioned pediatric oncologists and hematologist from Greifswald, Rostock, Schwerin and Szczecin);
- Staff nurses from the centers participating in the project.
2.2. Implementation of the Cross-Border Network
2.2.1. Joint Medical Case Presentations with Family Integration
2.2.2. Creation of Courses for Physicians, Nurses and Students
- Seminars;
- Case presentations;
- Telemedicine online OncoGroup meetings as a continuation of the activities of the OncoGroup.
3. Results
3.1. General Results
3.2. Integration of Families into the Network Activities
3.3. Joint Education Offers Using the Examples of Case Presentations and Seminars for Students and Physicians
3.3.1. Assessment and Assessment Tools
- (1)
- All presenters of the seminars were obliged to prepare a test with three multiple-choice questions related to the topic. Participants were asked to solve the test before the seminar and repeat it when the seminar was over. Answers were compared and analyzed. Tests scoring 0 or 1 correct answers were considered negative, whereas those scoring 2 or 3 were classified as positive.
- (2)
- To assess the participants’ contentment, the attendees were asked to scan a QR code that connected them with an online survey to answer several questions designed to measure their opinion regarding the content and form of the presentation. In addition, participation was possible via a paper version of the questionnaire. These data were subsequently analyzed by the project coordinator.
3.3.2. Results of the Pre-Seminar and After-Seminar Tests
3.3.3. Assessment of the Project Participants’ and Lecturers’ Contentment
3.4. Identified Barriers
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Statistisches Bundesamt. Bevölkerungsdichte in Mecklenburg-Vorpommern von 1995 bis 2021 (Einwohner je km2) [Graph]. Statista. 1 September 2022. Available online: https://de.statista.com/statistik/daten/studie/258841/umfrage/bevoelkerungsdichte-in-mecklenburg-vorpommern/ (accessed on 15 February 2023).
- Główny Urząd Statystyczny. Available online: https://stat.gov.pl/obszary-tematyczne/roczniki-statystyczne/roczniki-statystyczne/rocznik-demograficzny-2022,3,16.html (accessed on 15 February 2023).
- Hartvigsen, G.; Pedersen, S. Lessons Learned from 25 Years with Telemedicine in Northern Norway; Norwegian Centre for Integrated Care and Telemedicine, University Hospital of North Norway: Tromsø, Norway, 2015. [Google Scholar]
- Brady, C.J.; D’Amico, S.; Withers, N.; Kim, B.Y. Using public datasets to identify priority areas for ocular telehealth. Telemed. J. eHealth 2021, 27, 1293–1298. [Google Scholar] [CrossRef] [PubMed]
- Hosten, N.; Rosenberg, B.; Kram, A. Project Report on Telemedicine: What We Learned about the Administration and Development of a Binational Digital Infrastructure Project. Healthcare 2021, 9, 400. [Google Scholar] [CrossRef] [PubMed]
- American Society of Clinical Oncology (ASCO). Neuroblastoma—Childhood: Statistics. Available online: https://www.cancer.net/cancer-types/neuroblastoma-childhood/statistics (accessed on 1 March 2023).
- Jerzy Kowalczyk. Available online: https://www.mp.pl/podrecznik/pediatria/chapter/B42.71.13 (accessed on 1 March 2023).
- Simon, T.; Hero, B.; Schulte, J.H.; Deubzer, H.; Hundsdoerfer, P.; von Schweinitz, D.; Fuchs, J.; Schmidt, M.; Prasad, V.; Krug, B.; et al. 2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors. Klin. Padiatr. 2017, 229, 147–167. [Google Scholar] [CrossRef] [PubMed]
- Beuken, J.A.; Bouwmans, M.E.J.; Verstegen, D.M.L.; Dolmans, D.H.J.M. Out of sight, out of mind? A qualitative study of patients’ perspectives on cross-border healthcare in a European border region. Patient Educ. Couns. 2021, 104, 2559–2564. [Google Scholar] [CrossRef] [PubMed]
- Ladenstein, R.; Pötschger, U.; Valteau-Couanet, D.; Luksch, R.; Castel, V.; Ash, S.; Laureys, G.; Brock, P.; Michon, J.M.; Owens, C.; et al. Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1). Cancers 2020, 12, 309. [Google Scholar] [CrossRef] [PubMed]
- Johnson, K.; McGlynn, B.; Saggio, J.; Baniewicz, D.; Zhuang, H.; Maris, J.M.; Mosse, Y.P. Safety and efficacy of tandem 131I-metaiodobenzylguanidine infusions in relapsed/refractory neuroblastoma. Pediatr. Blood Cancer 2011, 57, 1124–1129. [Google Scholar] [CrossRef] [PubMed]
- Wieczorek, A.; Manzitti, C.; Garaventa, A.; Gray, J.; Papadakis, V.; Valteau-Couanet, D.; Zachwieja, K.; Poetschger, U.; Pribill, I.; Fiedler, S.; et al. Clinical Phenotype and Management of Severe Neurotoxicity Observed in Patients with Neuroblastoma Treated with Dinutuximab Beta in Clinical Trials. Cancers 2022, 14, 1919. [Google Scholar] [CrossRef] [PubMed]
- Al-Jadiry, M.F.; Uccini, S.; Testi, A.M.; Moleti, M.L.; Alsaadawi, A.R.; Al-Darraji, A.F.; Al-Saeed, R.M.; Faraj Al-Badri, S.A.; Sabhan, A.H.; Ghali, H.H.; et al. Comprehensive global collaboration in the care of 1182 pediatric oncology patients over 12 years: The Iraqi-Italian experience. Cancer Med. 2023, 12, 256–265. [Google Scholar] [CrossRef]
- Matthay, K.K.; Hylton, J.; Penumarthy, N.; Khattab, M.; Soh, S.Y.; Nguyen, H.T.K.; Alcasabas, A.P.; Fawzy, M.; Saab, R.; Khan, M.S.; et al. Global Neuroblastoma Network: An international multidisciplinary neuroblastoma tumor board for resource-limited countries. Pediatr. Blood Cancer 2022, 69, e29568. [Google Scholar] [CrossRef]
- Shah, A.C.; O’Dwyer, L.C.; Badawy, S.M. Telemedicine in Malignant and Nonmalignant Hematology: Systematic Review of Pediatric and Adult Studies. JMIR Mhealth Uhealth 2021, 9, e29619. [Google Scholar] [CrossRef]
Solid Tumors | Leukemia/Hematology | Oncological Emergencies, Complications, Infections |
---|---|---|
Childhood Lymphoma | Disorders of coagulation | Emergencies in pediatric oncology |
Diffuse intrinsic pontine glioma in children | New treatment options in leukemia | Invasive fungal infections |
Neuroblastoma 4s— diagnosis and management | Acute myeloblastic leukemia– new treatment approach AML in special groups (down syndrome), APL | Flow cytometry in leukemia– diagnosis |
Hepatocarcinoma in children | Anaemia–differential diagnosis and therapy | Supportive treatment in pediatric oncology |
Hodgkin lymphoma— new treatment options, relapse treatment, special groups | Causes of neutropenia in children | |
When to consider a brain tumor | Immune thrombocytopenia | |
Neuroblastoma— how to diagnose, how to treat | Approach to childhood leukemia | |
Immunotherapy in pediatric oncology |
|
|
Type of Event | Number of Events | Number of Participants | Participants/Event (Average) |
---|---|---|---|
Seminars for students/physicians | 14 | 565 | 40.2 |
Seminars for nurses | 5 | 77 | 15.4 |
Case presentations | 58 | 1365 | 23.5 |
Telemedicine Online Meetings | 8 | 119 | 14.8 |
Conferences | 2 | 102 | 51 |
Internships | 3 | 7 | 2.3 |
BEFORE-SEMINAR TEST | AFTER-SEMINAR TEST | |||
---|---|---|---|---|
NEGATIVE (Score 0–1) | POSITIVE (Score 2–3) | NEGATIVE (Score 0–1) | POSITIVE (Score 2–3) | |
SEMINAR | ||||
1 | 0.40 | 0.60 | 0.10 | 0.90 |
2 | 0.65 | 0.35 | 0.08 | 0.92 |
3 | 0.44 | 0.60 | 0.00 | 1.00 |
4 | 0.00 | 1.00 | 0.10 | 0.86 |
5 | 0.26 | 0.74 | 0.16 | 0.84 |
6 | 0.06 | 0.94 | 0.08 | 0.92 |
7 | 0.61 | 0.40 | 0.28 | 0.72 |
8 | 0.31 | 0.69 | 0.00 | 1.00 |
9 | 0.43 | 0.57 | 0.00 | 1.00 |
10 | 0.09 | 0.91 | 0.00 | 1.00 |
11 | 0.91 | 0.10 | 0.69 | 0.31 |
12 | 0.55 | 0.45 | 0.28 | 0.72 |
13 | 0.22 | 0.78 | 0.07 | 0.93 |
14 | 0.80 | 0.20 | 0.00 | 1.00 |
MEAN | 0.41 | 0.59 | 0.13 | 0.87 |
MIN. | 0.00 | 0.10 | 0.00 | 0.31 |
MAX. | 0.91 | 1.00 | 0.69 | 1.00 |
MEDIAN | 0.41 | 0.60 | 0.26 | 0.92 |
Telemedical Network cross Border Activity | Involved Group (s) | Goals | Main Output Indicator | Outcome | Facilitators | Barriers |
---|---|---|---|---|---|---|
General technical connection of all network institutions. | Physicians, students, nurses. | Immediate uncomplicated regular medical exchange. Savings in travel and time costs. | Establishment. | Established successfully. | Funding support for the telemedical equipment and staff by Interreg-VA. | Need for intensive coordination in the areas of IT and data protection. |
Case discussions | Physicians. | Medical exchange with other experts. | Feasibility. | Established successfully. Positive feedback from the evaluations. | Physicians received professional support through exchanges with other experts. | Research and translation of materials. Compliance with data protection regulations. |
Patient and their care givers. | Participation in the process of diagnosis and treatment in terms of a better understanding. Avoiding travelling time and expenses. | Feasibility. | Feasible. | Overcoming language barriers with a translator. | Intensive preparations in advance (e.g., translation of materials). | |
Students. | Insights into the professional activities. | Evaluation by feedback. | Established successfully. Positive feedback from the evaluations. | Good English knowledge. | Cross-institutional scheduling. | |
Seminars for students and doctors | Physicians, students. | Exchange of special knowledge for teaching purposes. | Evaluation by feedback. | Established successfully. Positive feedback from the evaluations. | Good English knowledge. | Cross-institutional scheduling. |
Education offers for nurses | Nurses. | Imparting teaching content, harmonization of treatment standards. | Feasibility. | Established successfully. | Overcoming language barriers with a translator. | Cross-institutional scheduling. Limited staff availability due to the need for patient care. Long-term plannings necessary. |
Telemedicine online meeting | Physicians from the Temicare network and other cooperating clinics in Germany and Poland. | Exchange of medical experiences. | Feasibility. | Established successfully, alternately in Germany and Poland. | Expansion of network activity. | - |
Cloud with recorded seminar content | Physicians, students, nurses. | Flexible access to the teaching materials. | Feasibility. | Established successfully. | Flexibility in terms of time and place of learning. | Compliance with data protection regulations. |
Internships in partner institutions | Physicians, students, medical staff. | Extension of professional experience. | Feasibility. | Performed successfully. | Increase in identification with the network through interpersonal exchange. | Pandemic limitations in travellings. Long-term plannings necessary. Language barriers. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Troschke, T.; Wieczorek, A.; Kulinski, K.; Ociepa, T.; Zielezinska, K.; Lode, H.N.; Urasinski, T. Pediatric Hematology and Oncology Center Integrated by Telemedicine: Experience, Challenges and First Results of a Cross Border Network. Healthcare 2023, 11, 1431. https://doi.org/10.3390/healthcare11101431
Troschke T, Wieczorek A, Kulinski K, Ociepa T, Zielezinska K, Lode HN, Urasinski T. Pediatric Hematology and Oncology Center Integrated by Telemedicine: Experience, Challenges and First Results of a Cross Border Network. Healthcare. 2023; 11(10):1431. https://doi.org/10.3390/healthcare11101431
Chicago/Turabian StyleTroschke, Tabea, Aleksandra Wieczorek, Konrad Kulinski, Tomasz Ociepa, Karolina Zielezinska, Holger N. Lode, and Tomasz Urasinski. 2023. "Pediatric Hematology and Oncology Center Integrated by Telemedicine: Experience, Challenges and First Results of a Cross Border Network" Healthcare 11, no. 10: 1431. https://doi.org/10.3390/healthcare11101431
APA StyleTroschke, T., Wieczorek, A., Kulinski, K., Ociepa, T., Zielezinska, K., Lode, H. N., & Urasinski, T. (2023). Pediatric Hematology and Oncology Center Integrated by Telemedicine: Experience, Challenges and First Results of a Cross Border Network. Healthcare, 11(10), 1431. https://doi.org/10.3390/healthcare11101431